{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:33:29Z","timestamp":1790091209542,"version":"4.0.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T00:00:00Z","timestamp":1633478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T00:00:00Z","timestamp":1633478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81700450"],"award-info":[{"award-number":["81700450"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Clinical Research Plan of SHDC","award":["SHDC2020CR2009A"],"award-info":[{"award-number":["SHDC2020CR2009A"]}]},{"name":"Shanghai Municipal Key Clinical Specialty","award":["shslczdzk05703"],"award-info":[{"award-number":["shslczdzk05703"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To investigate the mechanism of 25 hydroxyvitamin D (25(OH)D) deficiency in children with biliary atresia (BA) and its effect on liver fibrosis. The serum vitamin D and 25(OH)D, and expression of 25 hydroxylase (CYP2R1 and CYP27A1) in the liver of BA patients were detected and compared with those in the control group. We investigated the effect of differential expression of CYP2R1 in hepatocytes on the expression of genes related to liver fibrosis in primary hepatic stellate cells (HSCs) of BA and animal models of cholestasis. The ratio of 25(OH)D\/vitamin D in the BA group was significantly lower than that in the control group. The mRNA and protein expression of CYP2R1 and CYP27A1 in liver tissue of the BA group was significantly lower than that in the control group. Exogenous active vitamin D (calcitriol) inhibited the proliferation and migration of primary HSCs isolated from BA patients, and reduced the expression of fibrosis-related genes in vitro. Downregulation of expression of CYP2R1 in hepatocytes increased expression of transforming growth factor (TGF)-\u03b21, collagen (Col)-1\u03b11 and tissue inhibitor of metalloproteinase (TIMP)-1, and decreased the expression of matrix metalloproteinase (MMP)-2 in cocultured primary HSCs of BA. Upregulation of expression of CYP2R1 in mice with bile duct ligation significantly increased the level of 25(OH)D, decreased the expression of TGF-\u03b21, Col-1\u03b11 and TIMP-1, and increased the expression of MMP-2. Children with BA have impaired vitamin D activation due to CYP2R1 deficiency. The dysactivation of vitamin D can promote the proliferation and activation of HSCs and participate in the development of hepatic fibrosis in BA.<\/jats:p>","DOI":"10.1038\/s41598-021-99158-3","type":"journal-article","created":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:10:54Z","timestamp":1633651854000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Effect and mechanism of vitamin D activation disorder on liver fibrosis in biliary atresia"],"prefix":"10.1038","volume":"11","author":[{"given":"Song","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijun","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuiran","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,6]]},"reference":[{"issue":"3","key":"99158_CR1","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/hep.29905","volume":"68","author":"JA Bezerra","year":"2018","unstructured":"Bezerra, J. A. et al. Biliary atresia: Clinical and research challenges for the Twenty-First Century. Hepatology 68(3), 1163\u20131173 (2018).","journal-title":"Hepatology"},{"issue":"3","key":"99158_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.clinre.2014.03.010","volume":"38","author":"B Fischler","year":"2014","unstructured":"Fischler, B. & Lamireau, T. Cholestasis in the newborn and infant. Clin. Res. Hepatol. Gastroenterol. 38(3), 263\u2013267 (2014).","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"2","key":"99158_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s12519-018-0203-1","volume":"15","author":"WJ Shen","year":"2019","unstructured":"Shen, W. J. et al. Liver fibrosis in biliary atresia. World J. Pediatr. 15(2), 117\u2013123 (2019).","journal-title":"World J. Pediatr."},{"key":"99158_CR4","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3389\/fimmu.2020.00329","volume":"11","author":"A Ortiz-Perez","year":"2020","unstructured":"Ortiz-Perez, A. et al. Innate immunity and pathogenesis of biliary atresia. Front Immunol. 11, 329 (2020).","journal-title":"Front Immunol."},{"issue":"4","key":"99158_CR5","first-page":"826","volume":"27","author":"MS Hasan","year":"2018","unstructured":"Hasan, M. S. et al. Role of liver biopsy in the diagnosis of neonatal cholestasis due to biliary atresia. Mymensingh. Med. J. 27(4), 826\u2013833 (2018).","journal-title":"Mymensingh. Med. J."},{"issue":"1","key":"99158_CR6","first-page":"58","volume":"16","author":"AE Kheir","year":"2016","unstructured":"Kheir, A. E. et al. Idiopathic neonatal hepatitis or extrahepatic biliary atresia? The role of liver biopsy. Sudan. J. Paediatr. 16(1), 58\u201362 (2016).","journal-title":"Sudan. J. Paediatr."},{"issue":"5","key":"99158_CR7","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.jpedsurg.2016.02.016","volume":"51","author":"JY Lee","year":"2016","unstructured":"Lee, J. Y. et al. The value of preoperative liver biopsy in the diagnosis of extrahepatic biliary atresia: A systematic review and meta-analysis. J. Pediatr. Surg. 51(5), 753\u2013761 (2016).","journal-title":"J. Pediatr. Surg."},{"issue":"10","key":"99158_CR8","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1007\/s00595-017-1502-1","volume":"47","author":"N Sakamoto","year":"2017","unstructured":"Sakamoto, N. et al. The accumulation of regulatory T cells in the hepatic hilar lymph nodes in biliary atresia. Surg. Today 47(10), 1282\u20131286 (2017).","journal-title":"Surg. Today"},{"issue":"3","key":"99158_CR9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3748\/wjg.v24.i3.387","volume":"24","author":"SY Pang","year":"2018","unstructured":"Pang, S. Y. et al. Autoimmune liver disease-related autoantibodies in patients with biliary atresia. World J. Gastroenterol. 24(3), 387\u2013396 (2018).","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"99158_CR10","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/hep.28851","volume":"65","author":"CS Lages","year":"2017","unstructured":"Lages, C. S. et al. The dendritic cell-T helper 17-macrophage axis controls cholangiocyte injury and disease progression in murine and human biliary atresia. Hepatology 65(1), 174\u2013188 (2017).","journal-title":"Hepatology"},{"issue":"4","key":"99158_CR11","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1002\/hep.24807","volume":"55","author":"SM Brindley","year":"2012","unstructured":"Brindley, S. M. et al. Cytomegalovirus-specific T-cell reactivity in biliary atresia at the time of diagnosis is associated with deficits in regulatory T cells. Hepatology 55(4), 1130\u20131138 (2012).","journal-title":"Hepatology"},{"issue":"10","key":"99158_CR12","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.jpedsurg.2015.03.001","volume":"50","author":"A Zani","year":"2015","unstructured":"Zani, A. et al. Cytomegalovirus-associated biliary atresia: An aetiological and prognostic subgroup. J. Pediatr. Surg. 50(10), 1739\u20131745 (2015).","journal-title":"J. Pediatr. Surg."},{"issue":"1","key":"99158_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s10020-018-0064-z","volume":"24","author":"T Guijarro","year":"2018","unstructured":"Guijarro, T. et al. Detrimental pro-senescence effects of vitamin D on lung fibrosis. Mol. Med. 24(1), 64 (2018).","journal-title":"Mol. Med."},{"issue":"2","key":"99158_CR14","first-page":"E38","volume":"62","author":"N Arfian","year":"2016","unstructured":"Arfian, N. et al. Vitamin D attenuates kidney fibrosis via reducing fibroblast expansion, inflammation, and epithelial cell apoptosis. Kobe. J. Med. Sci. 62(2), E38\u2013E44 (2016).","journal-title":"Kobe. J. Med. Sci."},{"key":"99158_CR15","doi-asserted-by":"publisher","first-page":"17638","DOI":"10.1038\/srep17638","volume":"5","author":"Z Zhang","year":"2015","unstructured":"Zhang, Z. et al. Preventive effects of vitamin D treatment on bleomycin-induced pulmonary fibrosis. Sci. Rep. 5, 17638 (2015).","journal-title":"Sci. Rep."},{"key":"99158_CR16","doi-asserted-by":"publisher","first-page":"6563","DOI":"10.1038\/srep06563","volume":"4","author":"Y Sun","year":"2014","unstructured":"Sun, Y. et al. Elevated serum 1,25(OH)2-vitamin D3 level attenuates renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction in kl\/kl mice. Sci. Rep. 4, 6563 (2014).","journal-title":"Sci. Rep."},{"issue":"4","key":"99158_CR17","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.ecl.2017.07.009","volume":"46","author":"V Rai","year":"2017","unstructured":"Rai, V. & Agrawal, D. K. Role of vitamin D in cardiovascular diseases. Endocrinol. Metab. Clin. North Am. 46(4), 1039\u20131059 (2017).","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"99158_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pupt.2019.01.003","volume":"55","author":"V Tzilas","year":"2019","unstructured":"Tzilas, V. et al. Vitamin D prevents experimental lung fibrosis and predicts survival in patients with idiopathic pulmonary fibrosis. Pulm. Pharmacol. Ther. 55, 17\u201324 (2019).","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"5","key":"99158_CR19","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1053\/jhep.2003.50176","volume":"37","author":"M Gascon-Barre","year":"2003","unstructured":"Gascon-Barre, M. et al. The normal liver harbors the vitamin D nuclear receptor in nonparenchymal and biliary epithelial cells. Hepatology 37(5), 1034\u20131042 (2003).","journal-title":"Hepatology"},{"issue":"4","key":"99158_CR20","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1002\/hep.23489","volume":"51","author":"S Petta","year":"2010","unstructured":"Petta, S. et al. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology 51(4), 1158\u20131167 (2010).","journal-title":"Hepatology"},{"issue":"2","key":"99158_CR21","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1007\/s12020-016-1152-x","volume":"55","author":"BB Yang","year":"2017","unstructured":"Yang, B. B. et al. Low vitamin D status is associated with advanced liver fibrosis in patients with nonalcoholic fatty liver disease. Endocrine 55(2), 582\u2013590 (2017).","journal-title":"Endocrine"},{"issue":"1","key":"99158_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.21873\/invivo.11456","volume":"33","author":"AR Buonomo","year":"2019","unstructured":"Buonomo, A. R. et al. Severe vitamin D deficiency increases mortality among patients with liver cirrhosis regardless of the presence of HCC. In Vivo 33(1), 177\u2013182 (2019).","journal-title":"In Vivo"},{"key":"99158_CR23","doi-asserted-by":"crossref","unstructured":"Konstantakis, C., Tselekouni, P. & Kalafateli, M., et al. Vitamin D deficiency in patients with liver cirrhosis (2016).","DOI":"10.20524\/aog.2016.0037"},{"issue":"19","key":"99158_CR24","doi-asserted-by":"publisher","first-page":"e20296","DOI":"10.1097\/MD.0000000000020296","volume":"99","author":"T Chen","year":"2020","unstructured":"Chen, T. et al. The effect of vitamin D supplementation on the progression of fibrosis in patients with chronic liver disease: A protocol for a systematic review and meta-analysis. Medicine (Baltimore) 99(19), e20296 (2020).","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"99158_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13063-019-3241-7","volume":"20","author":"S Ebrahimpour-Koujan","year":"2019","unstructured":"Ebrahimpour-Koujan, S. et al. Effects of vitamin D supplementation on liver fibrogenic factors in non-alcoholic fatty liver patients with steatohepatitis: Study protocol for a randomized clinical trial. Trials 20(1), 153 (2019).","journal-title":"Trials"},{"issue":"6","key":"99158_CR26","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.jhep.2009.01.015","volume":"50","author":"A Tanaka","year":"2009","unstructured":"Tanaka, A. et al. Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations. J. Hepatol. 50(6), 1202\u20131209 (2009).","journal-title":"J. Hepatol."},{"issue":"7","key":"99158_CR27","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.dld.2018.12.022","volume":"51","author":"T Arai","year":"2019","unstructured":"Arai, T. et al. Association of vitamin D levels and vitamin D-related gene polymorphisms with liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease. Dig. Liver Dis. 51(7), 1036\u20131042 (2019).","journal-title":"Dig. Liver Dis."},{"issue":"12","key":"99158_CR28","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1136\/gut.2010.234666","volume":"60","author":"S Abramovitch","year":"2011","unstructured":"Abramovitch, S. et al. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats. Gut 60(12), 1728\u20131737 (2011).","journal-title":"Gut"},{"issue":"12","key":"99158_CR29","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1038\/s41374-019-0310-1","volume":"99","author":"FP Reiter","year":"2019","unstructured":"Reiter, F. P. et al. Antifibrotic effects of hypocalcemic vitamin D analogs in murine and human hepatic stellate cells and in the CCl4 mouse model. Lab. Invest. 99(12), 1906\u20131917 (2019).","journal-title":"Lab. Invest."},{"issue":"2","key":"99158_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1677\/JOE-08-0241","volume":"200","author":"JN Artaza","year":"2009","unstructured":"Artaza, J. N. & Norris, K. C. Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells. J. Endocrinol. 200(2), 207\u2013221 (2009).","journal-title":"J. Endocrinol."},{"issue":"3","key":"99158_CR31","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.cell.2013.03.028","volume":"153","author":"N Ding","year":"2013","unstructured":"Ding, N. et al. A vitamin D receptor\/SMAD genomic circuit gates hepatic fibrotic response. Cell 153(3), 601\u2013613 (2013).","journal-title":"Cell"},{"issue":"4","key":"99158_CR32","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3390\/nu10040496","volume":"10","author":"JT Keane","year":"2018","unstructured":"Keane, J. T. et al. Vitamin D and the liver-correlation or cause?. Nutrients 10(4), 496 (2018).","journal-title":"Nutrients"},{"issue":"5","key":"99158_CR33","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1136\/adc.54.5.367","volume":"54","author":"A Kobayashi","year":"1979","unstructured":"Kobayashi, A. et al. Serum 25-hydroxy-vitamin D in hepatobiliary disease in infancy. Arch. Dis. Child 54(5), 367\u2013370 (1979).","journal-title":"Arch. Dis. Child"},{"issue":"5","key":"99158_CR34","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1097\/MPG.0000000000001074","volume":"62","author":"J Ng","year":"2016","unstructured":"Ng, J. et al. Vitamin D levels in infants with biliary atresia: Pre- and post-kasai portoenterostomy. J. Pediatr. Gastroenterol. Nutr. 62(5), 746\u2013750 (2016).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"99158_CR35","doi-asserted-by":"publisher","first-page":"4621372","DOI":"10.1155\/2019\/4621372","volume":"2019","author":"P Zhuang","year":"2019","unstructured":"Zhuang, P. et al. Associations between vitamin D and liver function and liver fibrosis in patients with biliary atresia. Gastroenterol. Res. Pract. 2019, 4621372 (2019).","journal-title":"Gastroenterol. Res. Pract."},{"issue":"39","key":"99158_CR36","doi-asserted-by":"publisher","first-page":"38084","DOI":"10.1074\/jbc.M307028200","volume":"278","author":"JB Cheng","year":"2003","unstructured":"Cheng, J. B. et al. De-orphanization of cytochrome P450 2R1: A microsomal vitamin D 25-hydroxilase. J. Biol. Chem. 278(39), 38084\u201338093 (2003).","journal-title":"J. Biol. Chem."},{"issue":"20","key":"99158_CR37","doi-asserted-by":"publisher","first-page":"7711","DOI":"10.1073\/pnas.0402490101","volume":"101","author":"JB Cheng","year":"2004","unstructured":"Cheng, J. B. et al. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc. Natl. Acad. Sci. U S A 101(20), 7711\u20137715 (2004).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"1","key":"99158_CR38","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.bbrc.2004.09.073","volume":"324","author":"R Shinkyo","year":"2004","unstructured":"Shinkyo, R. et al. Metabolism of vitamin D by human microsomal CYP2R1. Biochem. Biophys. Res. Commun. 324(1), 451\u2013457 (2004).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"99158_CR39","first-page":"e218896","volume":"14","author":"C Peng","year":"2019","unstructured":"Peng, C. et al. Serum vitamin D level is inversely associated with liver fibrosis in post Kasai\u2019s portoenterostomy biliary atresia patients living with native liver. PLoS ONE 14(6), e218896 (2019).","journal-title":"PLoS ONE"},{"issue":"2","key":"99158_CR40","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1136\/gut.2005.088690","volume":"56","author":"Y Inagaki","year":"2007","unstructured":"Inagaki, Y. & Okazaki, I. Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis. Gut 56(2), 284\u2013292 (2007).","journal-title":"Gut"},{"key":"99158_CR41","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.biopha.2018.10.140","volume":"109","author":"W Udomsinprasert","year":"2019","unstructured":"Udomsinprasert, W. & Jittikoon, J. Vitamin D and liver fibrosis: Molecular mechanisms and clinical studies. Biomed. Pharmacother. 109, 1351\u20131360 (2019).","journal-title":"Biomed. Pharmacother."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99158-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99158-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99158-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T16:16:37Z","timestamp":1670084197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99158-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,6]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["99158"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-99158-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,6]]},"assertion":[{"value":"27 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19883"}}